Corticosteroids successfully treat multiple sclerosis relapses by reducing inflammation
the verdict
SUPPORTED
the evidence backs this
confidence 94/100
Corticosteroids are widely recognized and clinically proven to treat multiple sclerosis relapses by exerting potent anti-inflammatory effects that accelerate neurological recovery.
Evidence for · 3
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy
2013 · cited by 1,263
Paper [2] discusses the integral role of systemic corticosteroids in managing inflammatory conditions.
See more details
More for · 2
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.
1997 · cited by 422
Paper [7] evaluates the use of methylprednisolone, a corticosteroid, in combination therapy for active multiple sclerosis.
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
1987 · cited by 366
Paper [9] demonstrates through a controlled trial that high-dose methylprednisolone significantly improves clinical disability scores in acute multiple sclerosis relapses.